4-HO-MET
| Clinical data | |
|---|---|
| Other names | 4-Hydroxy-N-methyl-N-ethyltryptamine; 4-OH-MET; Metocin; Methylcybin |
| Routes of administration | Oral |
| Drug class | Serotonin receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 4–6 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H18N2O |
| Molar mass | 218.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-HO-MET, also known as 4-hydroxy-N-methyl-N-ethyltryptamine or as metocin, is a lesser-known psychedelic drug of the tryptamine family related to psilocin. It is a close structural and functional analogue of psilocin (4-HO-DMT) and is the 4-hydroxyl analogue of methylethyltryptamine (MET). The drug has been encountered as a novel recreational and designer drug.